What Are The Chances Of MiNK Therapeutics Inc. (INKT) Being A Good Investment?

MiNK Therapeutics Inc (NASDAQ:INKT) has a beta value of 0.26 and has seen 5.03 million shares traded in the last trading session. The company, currently valued at $161.86M, closed the last trade at $40.61 per share which meant it lost -$23.56 on the day or -36.71% during that session. The INKT stock price is -87.15% off its 52-week high price of $76.00 and 88.77% above the 52-week low of $4.56. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.29 million shares traded. The 3-month trading volume is 792.02K shares.

MiNK Therapeutics Inc (NASDAQ:INKT) trade information

Sporting -36.71% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the INKT stock price touched $40.61 or saw a rise of 46.57%. Year-to-date, MiNK Therapeutics Inc shares have moved 366.78%, while the 5-day performance has seen it change 479.32%. Over the past 30 days, the shares of MiNK Therapeutics Inc (NASDAQ:INKT) have changed 435.05%. Short interest in the company has seen 10657.0 shares shorted with days to cover at 2.44.

MiNK Therapeutics Inc (INKT) estimates and forecasts

The company’s shares have gained 420.64% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 16.86% over the past 5 years. Earnings growth for 2025 is a modest 30.94% while over the next 5 years, the company’s earnings are expected to increase by 15.43%.

INKT Dividends

MiNK Therapeutics Inc is expected to release its next earnings report on 2025-May-15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

MiNK Therapeutics Inc (NASDAQ:INKT)’s Major holders

Insiders own 74.40% of the company shares, while shares held by institutions stand at 1.58% with a share float percentage of 6.17%. Investors are also buoyed by the number of investors in a company, with MiNK Therapeutics Inc having a total of 22.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 0.23 million shares worth more than $0.22 million. As of 2024-06-30, VANGUARD GROUP INC held 0.676% of shares outstanding.

The other major institutional holder is LONGBOW FINANCE SA, with the holding of over 0.17 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.16 million and represent 0.4811% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 0.38% shares in the company for having 15.15 shares of worth $0.62 million while later fund manager owns 8.6 shares of worth $0.35 million as of Mar 31, 2025 , which makes it owner of about 0.22% of company’s outstanding stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.